Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells

Journal of Medical Virology

Volumn 78, Issue 2, 2006, Pages 216-222

  Andersson, Ida ^a   Lundkvist, Åke ^a   Haller, Otto ^b   Mirazimi, Ali ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Crimean Congo hemorrhagic fever virus; Endothelial cells; Interferon; MxA; siRNA

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GUANOSINE TRIPHOSPHATASE; INTERFERON; MYXOVIRUS RESISTANCE PROTEIN A; NUCLEOCAPSID PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; BIOLOGICAL WARFARE; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS; ENDOTHELIUM CELL; GROWTH INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; NAIRO VIRUS; NONHUMAN; TARGET CELL; VIROGENESIS; VIRUS HEMORRHAGIC FEVER; VIRUS IMMUNITY; VIRUS REPLICATION; VIRUS RESISTANCE;

ANTIVIRAL AGENTS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GTP-BINDING PROTEINS; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; INTERFERON-ALPHA; RNA INTERFERENCE; RNA, VIRAL;

ANIMALIA; CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; NAIROVIRUS; ORTHOMYXOVIRIDAE;

EID: 31144454382     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20530     Document Type: Article

References (26)

1. Andersson I, Bladh L, Mousavi-Jazi M, Magnusson KE, Lundkvist A, Haller O, Mirazimi A. 2004a. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J Virol 78: 4323-4329.
2. Andersson I, Simon M, Lundkvist A, Nilsson M, Holmstrom A, Elgh F, Mirazimi A. 2004b. Role of actin filaments in targeting of Crimean Congo hemorrhagic fever virus nucleocapsid protein to perinuclear regions of mammalian cells. J Med Virol 72:83-93.
3. Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, Haller O. 2004. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 78:9798-9806.
4. Bishop DH. 1996. Biology and molecular biology of bunyaviruses. New York, NY: Plenum press.
5. Bridgen A, Dalrymple DA, Weber F, Elliott RM. 2004. Inhibition of Dugbe nairovirus replication by human MxA protein. Virus Res 99:47-50.
6. Burney MI, Ghafoor A, Saleen M, Webb PA, Casals J. 1980. Nosocomial outbreak of viral hemorrhagic fever caused by Crimean Hemorrhagic fever-Congo virus in Pakistan, January 1976. Am J Trop Med Hyg 29:941-947.
7. Chinikar S, Persson SM, Johansson M, Bladh L, Goya M, Houshmand B, Mirazimi A, Plyusnin A, Lundkvist A, Nilsson M. 2004. Genetic analysis of Crimean-congo hemorrhagic fever virus in Iran. J Med Virol 73:404-411.
8. Flohr F, Schneider-Schaulies S, Haller O, Kochs G. 1999. The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures. FEBS Lett 463:24-28.
9. Frese M, Kochs G, Feldmann H, Hertkorn C, Haller O. 1996. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J Virol 70:915-923.
10. Geisbert TW, Jahrling PB. 2004. Exotic emerging viral diseases: Progress and challenges. Nat Med 10:8110-8121.
11. Hefti HP, Frese M, Landis H, Di Paolo C, Aguzzi A, Haller O, Pavlovic J. 1999. Human MxA protein protects mice lackinga functional alpha/beta interferon system against La crosse virus and other lethal viral infections. J Virol 73:6984-6991.
12. Hewson R, Chamberlain J, Mioulet V, Lloyd G, Jamil B, Hasan R, Gmyl A, Gmyl L, Smirnova SE, Lukashev A, Karganova G, CleggC. 2004. Crimean-Congo haemorrhagic fever virus: Sequence analysis of the small RNA segments from a collection of viruses world wide. Virus Res 102:185-189.
13. Kochs G, Janzen C, Hohenberg H, Haller O. 2002. Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc Natl Acad Sci USA 99:3153-3158.
14. Le Bon A, Tough DF. 2002. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 14:432-436.
15. Nichol S. 2001. Bunyaviruses. In: Fields BN DMKea, editor. Fields virology, 4th edition. Philadelpia: Lippincott, Williams and Wilkins.
16. Pavlovic J, Arzet HA, Hefti HP, Frese M, Rost D, Ernst B, Kolb E, Staeheli P, Haller O. 1995. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J Virol 69:4506-4510.
17. Peters CJ, Liu CT, Anderson GW, Jr, Morrill JC, Jahrling PB. 1989. Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev Infect Dis 11:8743-8749.
18. Samuel CE. 2001. Antiviral actions of interferons. Clin Microbiol Rev 14:778-809 , table of contents.
19. Schnittler HJ, Feldmann H. 2003. Viral hemorrhagic fever - A vascular disease? Thromb Haemost 89:967-972.
20. Suleiman MN, Muscat-Baron JM, Harries JR, Satti AG, Platt GS, Bowen ET, Simpson DI. 1980. Congo/Crimean haemorrhagic fever in Dubai. An outbreak at the Rashid Hospital. Lancet 2:939-941.
21. Swanepoel R. 1994. Crimean-Congo haemorrhagic fever. Cape Town: Oxford University Press, pp 723-729.
22. Swanepoel R, Shepherd AJ, Leman PA, Shepherd SP, McGillivray GM, Erasmus MJ, Searle LA, Gill DE. 1987. Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa. Am J Trop Med Hyg 36:120-132.
23. Tamura M, Asada H, Kondo K, Takahashi M, Yamanishi K. 1987. Effects of human and murine interferons against hemorrhagic fever with renal syndrome (HFRS) virus (Hantaan virus). Antiviral Res 8:171-178.
24. Temonen M, Lankinen H, Vapalahti O, Ronni T, Julkunen I, Vaheri A. 1995. Effect of interferon-alpha and cell differentiation on Puumala virus infection in human monocyte/macrophages. Virology 206:8-15.
25. Weber F, Bridgen A, Fazakerley JK, Streitenfeld H, Kessler N, Randall RE, Elliott RM. 2002. Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta Interferon. J Virol 76:7949-7955.
26. Whitehouse CA. 2004. Crimean-Congo hemorrhagic fever. Antiviral Res 64:145-160.